Healthcare | Advisory Council

Dr. Lange was a founder of CV Therapeutics and has served as the Chairman of the Board and Chief Executive Officer since August 1992. From July 1980 to August 1992, Dr. Lange served on the faculty of Washington University School of Medicine, including a position as Chief of Cardiology at the Jewish Hospital in St. Louis, Missouri from May 1985 to August 1992, and as a full Professor of Medicine from July 1990 until August 1992.

Dr. Lange is internationally recognized as an expert in the field of molecular mechanisms of cardiovascular disease. He holds a M.D. from Harvard Medical School and a Ph.D. in Biochemistry from Harvard University. He is currently on the Board of Trustees at the University of Rochester, and served as Chair of the Health Affairs Committee. Dr. Lange sits on an Advisory Committee for the Dean of Harvard Medical School for curriculum reform and support of medical education. He also serves on the Executive Committee of the Biotechnology Industry Organization (BIO), as well as the BIO Board of Directors, and he is the Chair of the Emerging Companies Governing Section. Dr. Lange sits on Boards of Directors of several private companies as well as Maxygen, a public company.